Global Human Tuberculosis Vaccine Market Research Report 2025(Status and Outlook)
Human tuberculosis vaccines are biological preparations designed to provide immunity against Mycobacterium tuberculosis, the bacterium responsible for tuberculosis (TB), primarily by stimulating the immune system to recognize and combat the pathogen, with the most widely used being the Bacille Calmette-Guerin (BCG) vaccine, which has been in use for nearly a century and is administered mainly to infants and young children in high-burden regions to prevent severe forms of the disease such as TB meningitis and miliary TB, though its efficacy in preventing pulmonary TB in adults varies significantly. The global market for these vaccines is driven by high disease prevalence in low- and middle-income countries, particularly in parts of Asia and Africa, supported by initiatives from organizations like the World Health Organization and Gavi, the Vaccine Alliance, which emphasize vaccination in national immunization programs; however, the market faces challenges such as variable efficacy of the current BCG vaccine, supply chain complexities, cold storage requirements, and the urgent need for more effective next-generation vaccines, with several candidates in various stages of clinical development aiming to offer improved protection and broader applicability across age groups.
The global Human Tuberculosis Vaccine market size was estimated at USD 620.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Human Tuberculosis Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Human Tuberculosis Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Human Tuberculosis Vaccine market.
Global Human Tuberculosis Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GlaxoSmithKline
Merck
Serum Institute of India
Valneva
Archivel Farma
BIOFABRI (Zendal)
Japan BCG Laboratory
GreenSignal Bio Pharma
AJ Vaccines
Taj Pharma India
Biomed Lublin
Market Segmentation (by Type)
Intradermal
Percutaneous
Market Segmentation (by Application)
Pediatrics
Adults
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Tuberculosis Vaccine Market
Overview of the regional outlook of the Human Tuberculosis Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Tuberculosis Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Tuberculosis Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Human Tuberculosis Vaccine market size was estimated at USD 620.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Human Tuberculosis Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Human Tuberculosis Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Human Tuberculosis Vaccine market.
Global Human Tuberculosis Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GlaxoSmithKline
Merck
Serum Institute of India
Valneva
Archivel Farma
BIOFABRI (Zendal)
Japan BCG Laboratory
GreenSignal Bio Pharma
AJ Vaccines
Taj Pharma India
Biomed Lublin
Market Segmentation (by Type)
Intradermal
Percutaneous
Market Segmentation (by Application)
Pediatrics
Adults
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Tuberculosis Vaccine Market
Overview of the regional outlook of the Human Tuberculosis Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Tuberculosis Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Tuberculosis Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Human Tuberculosis Vaccine
1.2 Key Market Segments
1.2.1 Human Tuberculosis Vaccine Segment by Type
1.2.2 Human Tuberculosis Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN TUBERCULOSIS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Tuberculosis Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Human Tuberculosis Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN TUBERCULOSIS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Human Tuberculosis Vaccine Product Life Cycle
3.3 Global Human Tuberculosis Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Human Tuberculosis Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Human Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Human Tuberculosis Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Human Tuberculosis Vaccine Market Competitive Situation and Trends
3.8.1 Human Tuberculosis Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Human Tuberculosis Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HUMAN TUBERCULOSIS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Human Tuberculosis Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN TUBERCULOSIS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Human Tuberculosis Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Human Tuberculosis Vaccine Market
5.7 ESG Ratings of Leading Companies
6 HUMAN TUBERCULOSIS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Tuberculosis Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Human Tuberculosis Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Human Tuberculosis Vaccine Price by Type (2020-2025)
7 HUMAN TUBERCULOSIS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Tuberculosis Vaccine Market Sales by Application (2020-2025)
7.3 Global Human Tuberculosis Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Human Tuberculosis Vaccine Sales Growth Rate by Application (2020-2025)
8 HUMAN TUBERCULOSIS VACCINE MARKET SALES BY REGION
8.1 Global Human Tuberculosis Vaccine Sales by Region
8.1.1 Global Human Tuberculosis Vaccine Sales by Region
8.1.2 Global Human Tuberculosis Vaccine Sales Market Share by Region
8.2 Global Human Tuberculosis Vaccine Market Size by Region
8.2.1 Global Human Tuberculosis Vaccine Market Size by Region
8.2.2 Global Human Tuberculosis Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Human Tuberculosis Vaccine Sales by Country
8.3.2 North America Human Tuberculosis Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Human Tuberculosis Vaccine Sales by Country
8.4.2 Europe Human Tuberculosis Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Human Tuberculosis Vaccine Sales by Region
8.5.2 Asia Pacific Human Tuberculosis Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Human Tuberculosis Vaccine Sales by Country
8.6.2 South America Human Tuberculosis Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Human Tuberculosis Vaccine Sales by Region
8.7.2 Middle East and Africa Human Tuberculosis Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HUMAN TUBERCULOSIS VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Human Tuberculosis Vaccine by Region(2020-2025)
9.2 Global Human Tuberculosis Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Human Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Human Tuberculosis Vaccine Production
9.4.1 North America Human Tuberculosis Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Human Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Human Tuberculosis Vaccine Production
9.5.1 Europe Human Tuberculosis Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Human Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Human Tuberculosis Vaccine Production (2020-2025)
9.6.1 Japan Human Tuberculosis Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Human Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Human Tuberculosis Vaccine Production (2020-2025)
9.7.1 China Human Tuberculosis Vaccine Production Growth Rate (2020-2025)
9.7.2 China Human Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Basic Information
10.1.2 GlaxoSmithKline Human Tuberculosis Vaccine Product Overview
10.1.3 GlaxoSmithKline Human Tuberculosis Vaccine Product Market Performance
10.1.4 GlaxoSmithKline Business Overview
10.1.5 GlaxoSmithKline SWOT Analysis
10.1.6 GlaxoSmithKline Recent Developments
10.2 Merck
10.2.1 Merck Basic Information
10.2.2 Merck Human Tuberculosis Vaccine Product Overview
10.2.3 Merck Human Tuberculosis Vaccine Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Serum Institute of India
10.3.1 Serum Institute of India Basic Information
10.3.2 Serum Institute of India Human Tuberculosis Vaccine Product Overview
10.3.3 Serum Institute of India Human Tuberculosis Vaccine Product Market Performance
10.3.4 Serum Institute of India Business Overview
10.3.5 Serum Institute of India SWOT Analysis
10.3.6 Serum Institute of India Recent Developments
10.4 Valneva
10.4.1 Valneva Basic Information
10.4.2 Valneva Human Tuberculosis Vaccine Product Overview
10.4.3 Valneva Human Tuberculosis Vaccine Product Market Performance
10.4.4 Valneva Business Overview
10.4.5 Valneva Recent Developments
10.5 Archivel Farma
10.5.1 Archivel Farma Basic Information
10.5.2 Archivel Farma Human Tuberculosis Vaccine Product Overview
10.5.3 Archivel Farma Human Tuberculosis Vaccine Product Market Performance
10.5.4 Archivel Farma Business Overview
10.5.5 Archivel Farma Recent Developments
10.6 BIOFABRI (Zendal)
10.6.1 BIOFABRI (Zendal) Basic Information
10.6.2 BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Overview
10.6.3 BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Market Performance
10.6.4 BIOFABRI (Zendal) Business Overview
10.6.5 BIOFABRI (Zendal) Recent Developments
10.7 Japan BCG Laboratory
10.7.1 Japan BCG Laboratory Basic Information
10.7.2 Japan BCG Laboratory Human Tuberculosis Vaccine Product Overview
10.7.3 Japan BCG Laboratory Human Tuberculosis Vaccine Product Market Performance
10.7.4 Japan BCG Laboratory Business Overview
10.7.5 Japan BCG Laboratory Recent Developments
10.8 GreenSignal Bio Pharma
10.8.1 GreenSignal Bio Pharma Basic Information
10.8.2 GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Overview
10.8.3 GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Market Performance
10.8.4 GreenSignal Bio Pharma Business Overview
10.8.5 GreenSignal Bio Pharma Recent Developments
10.9 AJ Vaccines
10.9.1 AJ Vaccines Basic Information
10.9.2 AJ Vaccines Human Tuberculosis Vaccine Product Overview
10.9.3 AJ Vaccines Human Tuberculosis Vaccine Product Market Performance
10.9.4 AJ Vaccines Business Overview
10.9.5 AJ Vaccines Recent Developments
10.10 Taj Pharma India
10.10.1 Taj Pharma India Basic Information
10.10.2 Taj Pharma India Human Tuberculosis Vaccine Product Overview
10.10.3 Taj Pharma India Human Tuberculosis Vaccine Product Market Performance
10.10.4 Taj Pharma India Business Overview
10.10.5 Taj Pharma India Recent Developments
10.11 Biomed Lublin
10.11.1 Biomed Lublin Basic Information
10.11.2 Biomed Lublin Human Tuberculosis Vaccine Product Overview
10.11.3 Biomed Lublin Human Tuberculosis Vaccine Product Market Performance
10.11.4 Biomed Lublin Business Overview
10.11.5 Biomed Lublin Recent Developments
11 HUMAN TUBERCULOSIS VACCINE MARKET FORECAST BY REGION
11.1 Global Human Tuberculosis Vaccine Market Size Forecast
11.2 Global Human Tuberculosis Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Tuberculosis Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Human Tuberculosis Vaccine Market Size Forecast by Region
11.2.4 South America Human Tuberculosis Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Human Tuberculosis Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Human Tuberculosis Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Human Tuberculosis Vaccine by Type (2026-2033)
12.1.2 Global Human Tuberculosis Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Human Tuberculosis Vaccine by Type (2026-2033)
12.2 Global Human Tuberculosis Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Human Tuberculosis Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Human Tuberculosis Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Human Tuberculosis Vaccine
1.2 Key Market Segments
1.2.1 Human Tuberculosis Vaccine Segment by Type
1.2.2 Human Tuberculosis Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN TUBERCULOSIS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Tuberculosis Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Human Tuberculosis Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN TUBERCULOSIS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Human Tuberculosis Vaccine Product Life Cycle
3.3 Global Human Tuberculosis Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Human Tuberculosis Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Human Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Human Tuberculosis Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Human Tuberculosis Vaccine Market Competitive Situation and Trends
3.8.1 Human Tuberculosis Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Human Tuberculosis Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HUMAN TUBERCULOSIS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Human Tuberculosis Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN TUBERCULOSIS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Human Tuberculosis Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Human Tuberculosis Vaccine Market
5.7 ESG Ratings of Leading Companies
6 HUMAN TUBERCULOSIS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Tuberculosis Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Human Tuberculosis Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Human Tuberculosis Vaccine Price by Type (2020-2025)
7 HUMAN TUBERCULOSIS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Tuberculosis Vaccine Market Sales by Application (2020-2025)
7.3 Global Human Tuberculosis Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Human Tuberculosis Vaccine Sales Growth Rate by Application (2020-2025)
8 HUMAN TUBERCULOSIS VACCINE MARKET SALES BY REGION
8.1 Global Human Tuberculosis Vaccine Sales by Region
8.1.1 Global Human Tuberculosis Vaccine Sales by Region
8.1.2 Global Human Tuberculosis Vaccine Sales Market Share by Region
8.2 Global Human Tuberculosis Vaccine Market Size by Region
8.2.1 Global Human Tuberculosis Vaccine Market Size by Region
8.2.2 Global Human Tuberculosis Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Human Tuberculosis Vaccine Sales by Country
8.3.2 North America Human Tuberculosis Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Human Tuberculosis Vaccine Sales by Country
8.4.2 Europe Human Tuberculosis Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Human Tuberculosis Vaccine Sales by Region
8.5.2 Asia Pacific Human Tuberculosis Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Human Tuberculosis Vaccine Sales by Country
8.6.2 South America Human Tuberculosis Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Human Tuberculosis Vaccine Sales by Region
8.7.2 Middle East and Africa Human Tuberculosis Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HUMAN TUBERCULOSIS VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Human Tuberculosis Vaccine by Region(2020-2025)
9.2 Global Human Tuberculosis Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Human Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Human Tuberculosis Vaccine Production
9.4.1 North America Human Tuberculosis Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Human Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Human Tuberculosis Vaccine Production
9.5.1 Europe Human Tuberculosis Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Human Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Human Tuberculosis Vaccine Production (2020-2025)
9.6.1 Japan Human Tuberculosis Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Human Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Human Tuberculosis Vaccine Production (2020-2025)
9.7.1 China Human Tuberculosis Vaccine Production Growth Rate (2020-2025)
9.7.2 China Human Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Basic Information
10.1.2 GlaxoSmithKline Human Tuberculosis Vaccine Product Overview
10.1.3 GlaxoSmithKline Human Tuberculosis Vaccine Product Market Performance
10.1.4 GlaxoSmithKline Business Overview
10.1.5 GlaxoSmithKline SWOT Analysis
10.1.6 GlaxoSmithKline Recent Developments
10.2 Merck
10.2.1 Merck Basic Information
10.2.2 Merck Human Tuberculosis Vaccine Product Overview
10.2.3 Merck Human Tuberculosis Vaccine Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Serum Institute of India
10.3.1 Serum Institute of India Basic Information
10.3.2 Serum Institute of India Human Tuberculosis Vaccine Product Overview
10.3.3 Serum Institute of India Human Tuberculosis Vaccine Product Market Performance
10.3.4 Serum Institute of India Business Overview
10.3.5 Serum Institute of India SWOT Analysis
10.3.6 Serum Institute of India Recent Developments
10.4 Valneva
10.4.1 Valneva Basic Information
10.4.2 Valneva Human Tuberculosis Vaccine Product Overview
10.4.3 Valneva Human Tuberculosis Vaccine Product Market Performance
10.4.4 Valneva Business Overview
10.4.5 Valneva Recent Developments
10.5 Archivel Farma
10.5.1 Archivel Farma Basic Information
10.5.2 Archivel Farma Human Tuberculosis Vaccine Product Overview
10.5.3 Archivel Farma Human Tuberculosis Vaccine Product Market Performance
10.5.4 Archivel Farma Business Overview
10.5.5 Archivel Farma Recent Developments
10.6 BIOFABRI (Zendal)
10.6.1 BIOFABRI (Zendal) Basic Information
10.6.2 BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Overview
10.6.3 BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Market Performance
10.6.4 BIOFABRI (Zendal) Business Overview
10.6.5 BIOFABRI (Zendal) Recent Developments
10.7 Japan BCG Laboratory
10.7.1 Japan BCG Laboratory Basic Information
10.7.2 Japan BCG Laboratory Human Tuberculosis Vaccine Product Overview
10.7.3 Japan BCG Laboratory Human Tuberculosis Vaccine Product Market Performance
10.7.4 Japan BCG Laboratory Business Overview
10.7.5 Japan BCG Laboratory Recent Developments
10.8 GreenSignal Bio Pharma
10.8.1 GreenSignal Bio Pharma Basic Information
10.8.2 GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Overview
10.8.3 GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Market Performance
10.8.4 GreenSignal Bio Pharma Business Overview
10.8.5 GreenSignal Bio Pharma Recent Developments
10.9 AJ Vaccines
10.9.1 AJ Vaccines Basic Information
10.9.2 AJ Vaccines Human Tuberculosis Vaccine Product Overview
10.9.3 AJ Vaccines Human Tuberculosis Vaccine Product Market Performance
10.9.4 AJ Vaccines Business Overview
10.9.5 AJ Vaccines Recent Developments
10.10 Taj Pharma India
10.10.1 Taj Pharma India Basic Information
10.10.2 Taj Pharma India Human Tuberculosis Vaccine Product Overview
10.10.3 Taj Pharma India Human Tuberculosis Vaccine Product Market Performance
10.10.4 Taj Pharma India Business Overview
10.10.5 Taj Pharma India Recent Developments
10.11 Biomed Lublin
10.11.1 Biomed Lublin Basic Information
10.11.2 Biomed Lublin Human Tuberculosis Vaccine Product Overview
10.11.3 Biomed Lublin Human Tuberculosis Vaccine Product Market Performance
10.11.4 Biomed Lublin Business Overview
10.11.5 Biomed Lublin Recent Developments
11 HUMAN TUBERCULOSIS VACCINE MARKET FORECAST BY REGION
11.1 Global Human Tuberculosis Vaccine Market Size Forecast
11.2 Global Human Tuberculosis Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Tuberculosis Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Human Tuberculosis Vaccine Market Size Forecast by Region
11.2.4 South America Human Tuberculosis Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Human Tuberculosis Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Human Tuberculosis Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Human Tuberculosis Vaccine by Type (2026-2033)
12.1.2 Global Human Tuberculosis Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Human Tuberculosis Vaccine by Type (2026-2033)
12.2 Global Human Tuberculosis Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Human Tuberculosis Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Human Tuberculosis Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Tuberculosis Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Human Tuberculosis Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Human Tuberculosis Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Human Tuberculosis Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Human Tuberculosis Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Tuberculosis Vaccine as of 2024)
Table 10. Global Market Human Tuberculosis Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Human Tuberculosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Human Tuberculosis Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Human Tuberculosis Vaccine Sales by Type (K MT)
Table 26. Global Human Tuberculosis Vaccine Market Size by Type (M USD)
Table 27. Global Human Tuberculosis Vaccine Sales (K MT) by Type (2020-2025)
Table 28. Global Human Tuberculosis Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Human Tuberculosis Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Human Tuberculosis Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Human Tuberculosis Vaccine Price (USD/KG) by Type (2020-2025)
Table 32. Global Human Tuberculosis Vaccine Sales (K MT) by Application
Table 33. Global Human Tuberculosis Vaccine Market Size by Application
Table 34. Global Human Tuberculosis Vaccine Sales by Application (2020-2025) & (K MT)
Table 35. Global Human Tuberculosis Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Human Tuberculosis Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Human Tuberculosis Vaccine Market Share by Application (2020-2025)
Table 38. Global Human Tuberculosis Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Human Tuberculosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 40. Global Human Tuberculosis Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Human Tuberculosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Human Tuberculosis Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Human Tuberculosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 44. North America Human Tuberculosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Human Tuberculosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 46. Europe Human Tuberculosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Human Tuberculosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Human Tuberculosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Human Tuberculosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 50. South America Human Tuberculosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Human Tuberculosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Human Tuberculosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Human Tuberculosis Vaccine Production (K MT) by Region(2020-2025)
Table 54. Global Human Tuberculosis Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Human Tuberculosis Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Human Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Human Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Human Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Human Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Human Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. GlaxoSmithKline Basic Information
Table 62. GlaxoSmithKline Human Tuberculosis Vaccine Product Overview
Table 63. GlaxoSmithKline Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline SWOT Analysis
Table 66. GlaxoSmithKline Recent Developments
Table 67. Merck Basic Information
Table 68. Merck Human Tuberculosis Vaccine Product Overview
Table 69. Merck Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Merck Business Overview
Table 71. Merck SWOT Analysis
Table 72. Merck Recent Developments
Table 73. Serum Institute of India Basic Information
Table 74. Serum Institute of India Human Tuberculosis Vaccine Product Overview
Table 75. Serum Institute of India Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Serum Institute of India Business Overview
Table 77. Serum Institute of India SWOT Analysis
Table 78. Serum Institute of India Recent Developments
Table 79. Valneva Basic Information
Table 80. Valneva Human Tuberculosis Vaccine Product Overview
Table 81. Valneva Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Valneva Business Overview
Table 83. Valneva Recent Developments
Table 84. Archivel Farma Basic Information
Table 85. Archivel Farma Human Tuberculosis Vaccine Product Overview
Table 86. Archivel Farma Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Archivel Farma Business Overview
Table 88. Archivel Farma Recent Developments
Table 89. BIOFABRI (Zendal) Basic Information
Table 90. BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Overview
Table 91. BIOFABRI (Zendal) Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. BIOFABRI (Zendal) Business Overview
Table 93. BIOFABRI (Zendal) Recent Developments
Table 94. Japan BCG Laboratory Basic Information
Table 95. Japan BCG Laboratory Human Tuberculosis Vaccine Product Overview
Table 96. Japan BCG Laboratory Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Japan BCG Laboratory Business Overview
Table 98. Japan BCG Laboratory Recent Developments
Table 99. GreenSignal Bio Pharma Basic Information
Table 100. GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Overview
Table 101. GreenSignal Bio Pharma Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. GreenSignal Bio Pharma Business Overview
Table 103. GreenSignal Bio Pharma Recent Developments
Table 104. AJ Vaccines Basic Information
Table 105. AJ Vaccines Human Tuberculosis Vaccine Product Overview
Table 106. AJ Vaccines Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. AJ Vaccines Business Overview
Table 108. AJ Vaccines Recent Developments
Table 109. Taj Pharma India Basic Information
Table 110. Taj Pharma India Human Tuberculosis Vaccine Product Overview
Table 111. Taj Pharma India Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Taj Pharma India Business Overview
Table 113. Taj Pharma India Recent Developments
Table 114. Biomed Lublin Basic Information
Table 115. Biomed Lublin Human Tuberculosis Vaccine Product Overview
Table 116. Biomed Lublin Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Biomed Lublin Business Overview
Table 118. Biomed Lublin Recent Developments
Table 119. Global Human Tuberculosis Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 120. Global Human Tuberculosis Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 121. North America Human Tuberculosis Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 122. North America Human Tuberculosis Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 123. Europe Human Tuberculosis Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 124. Europe Human Tuberculosis Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 125. Asia Pacific Human Tuberculosis Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 126. Asia Pacific Human Tuberculosis Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 127. South America Human Tuberculosis Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 128. South America Human Tuberculosis Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 129. Middle East and Africa Human Tuberculosis Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 130. Middle East and Africa Human Tuberculosis Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 131. Global Human Tuberculosis Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 132. Global Human Tuberculosis Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 133. Global Human Tuberculosis Vaccine Price Forecast by Type (2026-2033) & (USD/KG)
Table 134. Global Human Tuberculosis Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 135. Global Human Tuberculosis Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Tuberculosis Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Human Tuberculosis Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Human Tuberculosis Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Human Tuberculosis Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Human Tuberculosis Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Tuberculosis Vaccine as of 2024)
Table 10. Global Market Human Tuberculosis Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Human Tuberculosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Human Tuberculosis Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Human Tuberculosis Vaccine Sales by Type (K MT)
Table 26. Global Human Tuberculosis Vaccine Market Size by Type (M USD)
Table 27. Global Human Tuberculosis Vaccine Sales (K MT) by Type (2020-2025)
Table 28. Global Human Tuberculosis Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Human Tuberculosis Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Human Tuberculosis Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Human Tuberculosis Vaccine Price (USD/KG) by Type (2020-2025)
Table 32. Global Human Tuberculosis Vaccine Sales (K MT) by Application
Table 33. Global Human Tuberculosis Vaccine Market Size by Application
Table 34. Global Human Tuberculosis Vaccine Sales by Application (2020-2025) & (K MT)
Table 35. Global Human Tuberculosis Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Human Tuberculosis Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Human Tuberculosis Vaccine Market Share by Application (2020-2025)
Table 38. Global Human Tuberculosis Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Human Tuberculosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 40. Global Human Tuberculosis Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Human Tuberculosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Human Tuberculosis Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Human Tuberculosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 44. North America Human Tuberculosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Human Tuberculosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 46. Europe Human Tuberculosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Human Tuberculosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Human Tuberculosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Human Tuberculosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 50. South America Human Tuberculosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Human Tuberculosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Human Tuberculosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Human Tuberculosis Vaccine Production (K MT) by Region(2020-2025)
Table 54. Global Human Tuberculosis Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Human Tuberculosis Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Human Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Human Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Human Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Human Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Human Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. GlaxoSmithKline Basic Information
Table 62. GlaxoSmithKline Human Tuberculosis Vaccine Product Overview
Table 63. GlaxoSmithKline Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline SWOT Analysis
Table 66. GlaxoSmithKline Recent Developments
Table 67. Merck Basic Information
Table 68. Merck Human Tuberculosis Vaccine Product Overview
Table 69. Merck Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Merck Business Overview
Table 71. Merck SWOT Analysis
Table 72. Merck Recent Developments
Table 73. Serum Institute of India Basic Information
Table 74. Serum Institute of India Human Tuberculosis Vaccine Product Overview
Table 75. Serum Institute of India Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Serum Institute of India Business Overview
Table 77. Serum Institute of India SWOT Analysis
Table 78. Serum Institute of India Recent Developments
Table 79. Valneva Basic Information
Table 80. Valneva Human Tuberculosis Vaccine Product Overview
Table 81. Valneva Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Valneva Business Overview
Table 83. Valneva Recent Developments
Table 84. Archivel Farma Basic Information
Table 85. Archivel Farma Human Tuberculosis Vaccine Product Overview
Table 86. Archivel Farma Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Archivel Farma Business Overview
Table 88. Archivel Farma Recent Developments
Table 89. BIOFABRI (Zendal) Basic Information
Table 90. BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Overview
Table 91. BIOFABRI (Zendal) Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. BIOFABRI (Zendal) Business Overview
Table 93. BIOFABRI (Zendal) Recent Developments
Table 94. Japan BCG Laboratory Basic Information
Table 95. Japan BCG Laboratory Human Tuberculosis Vaccine Product Overview
Table 96. Japan BCG Laboratory Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Japan BCG Laboratory Business Overview
Table 98. Japan BCG Laboratory Recent Developments
Table 99. GreenSignal Bio Pharma Basic Information
Table 100. GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Overview
Table 101. GreenSignal Bio Pharma Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. GreenSignal Bio Pharma Business Overview
Table 103. GreenSignal Bio Pharma Recent Developments
Table 104. AJ Vaccines Basic Information
Table 105. AJ Vaccines Human Tuberculosis Vaccine Product Overview
Table 106. AJ Vaccines Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. AJ Vaccines Business Overview
Table 108. AJ Vaccines Recent Developments
Table 109. Taj Pharma India Basic Information
Table 110. Taj Pharma India Human Tuberculosis Vaccine Product Overview
Table 111. Taj Pharma India Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Taj Pharma India Business Overview
Table 113. Taj Pharma India Recent Developments
Table 114. Biomed Lublin Basic Information
Table 115. Biomed Lublin Human Tuberculosis Vaccine Product Overview
Table 116. Biomed Lublin Human Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Biomed Lublin Business Overview
Table 118. Biomed Lublin Recent Developments
Table 119. Global Human Tuberculosis Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 120. Global Human Tuberculosis Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 121. North America Human Tuberculosis Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 122. North America Human Tuberculosis Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 123. Europe Human Tuberculosis Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 124. Europe Human Tuberculosis Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 125. Asia Pacific Human Tuberculosis Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 126. Asia Pacific Human Tuberculosis Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 127. South America Human Tuberculosis Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 128. South America Human Tuberculosis Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 129. Middle East and Africa Human Tuberculosis Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 130. Middle East and Africa Human Tuberculosis Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 131. Global Human Tuberculosis Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 132. Global Human Tuberculosis Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 133. Global Human Tuberculosis Vaccine Price Forecast by Type (2026-2033) & (USD/KG)
Table 134. Global Human Tuberculosis Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 135. Global Human Tuberculosis Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Human Tuberculosis Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Tuberculosis Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Human Tuberculosis Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Human Tuberculosis Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Tuberculosis Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Human Tuberculosis Vaccine Product Life Cycle
Figure 13. Human Tuberculosis Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Human Tuberculosis Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Human Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Human Tuberculosis Vaccine Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Human Tuberculosis Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Human Tuberculosis Vaccine
Figure 19. Global Human Tuberculosis Vaccine Market PEST Analysis
Figure 20. Global Human Tuberculosis Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Human Tuberculosis Vaccine Market Share by Type
Figure 27. Sales Market Share of Human Tuberculosis Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Human Tuberculosis Vaccine by Type in 2024
Figure 29. Market Size Share of Human Tuberculosis Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Human Tuberculosis Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Human Tuberculosis Vaccine Market Share by Application
Figure 33. Global Human Tuberculosis Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Human Tuberculosis Vaccine Sales Market Share by Application in 2024
Figure 35. Global Human Tuberculosis Vaccine Market Share by Application (2020-2025)
Figure 36. Global Human Tuberculosis Vaccine Market Share by Application in 2024
Figure 37. Global Human Tuberculosis Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Human Tuberculosis Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Human Tuberculosis Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Human Tuberculosis Vaccine Sales Market Share by Country in 2024
Figure 43. North America Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Human Tuberculosis Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Human Tuberculosis Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Human Tuberculosis Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Human Tuberculosis Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Human Tuberculosis Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Human Tuberculosis Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Human Tuberculosis Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Human Tuberculosis Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Human Tuberculosis Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Human Tuberculosis Vaccine Market Size Market Share by Region in 2024
Figure 68. China Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Human Tuberculosis Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Human Tuberculosis Vaccine Sales Market Share by Country in 2024
Figure 80. South America Human Tuberculosis Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Human Tuberculosis Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Human Tuberculosis Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Human Tuberculosis Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Human Tuberculosis Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Human Tuberculosis Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Human Tuberculosis Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Human Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Human Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Human Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Human Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Human Tuberculosis Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Human Tuberculosis Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Human Tuberculosis Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Human Tuberculosis Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Human Tuberculosis Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Human Tuberculosis Vaccine Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Human Tuberculosis Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Tuberculosis Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Human Tuberculosis Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Human Tuberculosis Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Tuberculosis Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Human Tuberculosis Vaccine Product Life Cycle
Figure 13. Human Tuberculosis Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Human Tuberculosis Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Human Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Human Tuberculosis Vaccine Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Human Tuberculosis Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Human Tuberculosis Vaccine
Figure 19. Global Human Tuberculosis Vaccine Market PEST Analysis
Figure 20. Global Human Tuberculosis Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Human Tuberculosis Vaccine Market Share by Type
Figure 27. Sales Market Share of Human Tuberculosis Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Human Tuberculosis Vaccine by Type in 2024
Figure 29. Market Size Share of Human Tuberculosis Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Human Tuberculosis Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Human Tuberculosis Vaccine Market Share by Application
Figure 33. Global Human Tuberculosis Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Human Tuberculosis Vaccine Sales Market Share by Application in 2024
Figure 35. Global Human Tuberculosis Vaccine Market Share by Application (2020-2025)
Figure 36. Global Human Tuberculosis Vaccine Market Share by Application in 2024
Figure 37. Global Human Tuberculosis Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Human Tuberculosis Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Human Tuberculosis Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Human Tuberculosis Vaccine Sales Market Share by Country in 2024
Figure 43. North America Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Human Tuberculosis Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Human Tuberculosis Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Human Tuberculosis Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Human Tuberculosis Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Human Tuberculosis Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Human Tuberculosis Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Human Tuberculosis Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Human Tuberculosis Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Human Tuberculosis Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Human Tuberculosis Vaccine Market Size Market Share by Region in 2024
Figure 68. China Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Human Tuberculosis Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Human Tuberculosis Vaccine Sales Market Share by Country in 2024
Figure 80. South America Human Tuberculosis Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Human Tuberculosis Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Human Tuberculosis Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Human Tuberculosis Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Human Tuberculosis Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Human Tuberculosis Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Human Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Human Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Human Tuberculosis Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Human Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Human Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Human Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Human Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Human Tuberculosis Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Human Tuberculosis Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Human Tuberculosis Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Human Tuberculosis Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Human Tuberculosis Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Human Tuberculosis Vaccine Market Share Forecast by Application (2026-2033)
